Attached files
| file | filename |
|---|---|
| 10-K - FORM 10-K - Alexza Pharmaceuticals Inc. | f55133e10vk.htm |
| EX-32.1 - EX-32.1 - Alexza Pharmaceuticals Inc. | f55133exv32w1.htm |
| EX-21.1 - EX-21.1 - Alexza Pharmaceuticals Inc. | f55133exv21w1.htm |
| EX-31.2 - EX-31.2 - Alexza Pharmaceuticals Inc. | f55133exv31w2.htm |
| EX-31.1 - EX-31.1 - Alexza Pharmaceuticals Inc. | f55133exv31w1.htm |
| EX-10.55 - EX-10.55 - Alexza Pharmaceuticals Inc. | f55133exv10w55.htm |
| EX-10.56 - EX-10.56 - Alexza Pharmaceuticals Inc. | f55133exv10w56.htm |
Exhibit 23.1
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration
Statements on
Form S-8
(Nos.
333-132593,
333-141718,
333-149129,
333-157885,
333-162485,
333-164843
and
333-151303)
pertaining to the 2005 Equity Incentive Plan, 2005 Non-Employee
Directors’ Stock Option Plan and 2005 Employee Stock
Purchase Plan of Alexza Pharmaceuticals, Inc., the Registration
Statements on
Form S-3
(Nos.
333-141739
and
333-141724)
and the related prospectuses of Alexza Pharmaceuticals, Inc.,
and the Registration Statements on
Form S-1
(Nos. 333-161804
and
333-162582)
and the related prospectuses of Alexza Pharmaceuticals, Inc. of
our reports dated March 9, 2010, with respect to the
consolidated financial statements of Alexza Pharmaceuticals,
Inc. and the effectiveness of internal control over financial
reporting of Alexza Pharmaceuticals, Inc., included in this
Annual Report
(Form 10-K)
for the year ended December 31, 2009.
/s/ Ernst & Young LLP
Palo Alto, California
March 9, 2010